2019 -
now Exe. Director, Discovery Biology and Pharmacology @ H3biomedicine Inc
2011 -
2018 Sr. Director, Cancer Immunotherapy Discovery @
2005 -
2011 Staff Scientist @
2002 -
2005 JSPS postdoctoral fellow @
Xingfeng Bao Education
Graduate School of Chinese Academy of Sciences
Ph.D. (Chemistry and Pharmacology)
1997
-
2002
Xingfeng Bao Skills
Drug Discovery
Biochemistry
Drug Development
Cell
Immunology
Molecular Biology
Pharmacology
In Vitro
Oncology
Protein Chemistry
Pharmaceutical Industry
Cell Biology
Animal Models
Cancer Research
Flow Cytometry
Biomarker Discovery
In Vivo
Immunohistochemistry
Western Blotting
Signal Transduction
Confocal Microscopy
Lead Change
Molecular Cloning
Biomarkers
Translational Biomarkers
Immuno-oncology
cancer immunotherapy
Cell Signaling
Translational pharmacology
Antibody characterization
protein engineering
glycoscience
Cell adhesion
Immune cell trafficking
Immune response
Antibody
Biotechnology
Project Management
Translational
Cancer
Immuno Oncology
Strategic Planning
Research
PowerPoint
Customer Service
Leadership
Cell Culture
Xingfeng Bao Summary
Xingfeng Bao, based in Cambridge, MA, US, is currently a VP of Biology at GV20 Therapeutics. Xingfeng Bao brings experience from previous roles at H3biomedicine Inc, Eisai US, Sanford|Burnham Medical Research Institute and Kobe Pharmaceutical University. Xingfeng Bao holds a 1997 - 2002 Ph.D. in Chemistry and Pharmacology @ Graduate School of Chinese Academy of Sciences. With a robust skill set that includes Drug Discovery, Biochemistry, Drug Development, Cell, Immunology and more. Xingfeng Bao has 3 emails and 2 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.